Star Combo Pharma (S66) Stock Price, News & Analysis

Company Overview

Star Combo Pharma Limited engages in the manufacturing and distribution of health food products and nutritional supplements in Australia and China. It operates in two segments, OEM Division and Austoyou Retail. The company develops, manufactures, markets, and sells natural health supplements and skin care products. It also provides its products through e-commerce platform to Chinese health product consumers. The company sells its products under the Costar, Living Healthy, Amax, and J&K brands. Star Combo Pharma Limited was founded in 2004 and is headquartered in Smithfield, Australia.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: N/A
• Market Capitalization: A$17.55 million
• P/E Ratio: 21.68
• Dividend Yield: 2.85%
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: ASX
• Sector: Consumer Defensive
• Industry: Household & Personal Products
• Sub-Industry: N/A
• Current Symbol: ASX:S66
• CIK: N/A
• Web: www.starcombo.com.au
• Phone: 61-2-9756-6555
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): A$0.01
• Trailing P/E Ratio: 21.68
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: 2.52%
• Pretax Margin: N/A
• Return on Equity: 2.43%
• Return on Assets: 1.36%

Debt

• Debt-to-Equity Ratio: 12.09
• Current Ratio: 3.77
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: A$26.02 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: A$0.25 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 135,080,000
• Free Float: N/A
• Market Cap: A$17.55 million
• Optionable: N/A
• Beta: 0.42